catechin has been researched along with Pulmonary Fibrosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, D; Li, LC; Ma, QQ; Shen, WW; Yao, JJ | 1 |
| Dong, L; Fan, J; Fan, X; Gong, Y; Jiang, X; Jin, P; Li, L; Mao, S; Quan, Y; Wang, S; Wang, Y; Zhang, T | 1 |
| Chapman, HA; Decaris, M; Foster, E; Golden, JA; Hills, NK; Jones, KD; Kotak, P; Le Saux, CJ; Leong, D; Linderholm, AL; Montas, G; Oldham, JM; Song, JW; Trinh, BN; Turner, S; Wei, Y; Wolters, PJ | 1 |
| Bertoldi, M; Campagnari, R; Crupi, R; Cuzzocrea, S; Di Paola, R; Menegazzi, M | 1 |
| Kalantar, H; Khodayar, MJ; Mansouri, E; Pashmforoosh, M; Shariati, S | 1 |
| Liu, Y; Sun, WL; Wang, L; Wang, Y; Wei, L; Yang, ZL; You, H; Zhang, WJ; Zheng, K | 1 |
| Kalayarasan, S; Sriram, N; Sudhandiran, G | 3 |
| Albini, A; Benelli, R; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M | 1 |
| Biggin, S; Caniato, R; Dell'Aica, I; Garbisa, S | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
3 review(s) available for catechin and Pulmonary Fibrosis
| Article | Year |
|---|---|
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Topics: Anti-Inflammatory Agents; Antioxidants; Autoimmune Diseases; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; NF-kappa B; Pandemics; Plant Extracts; Pneumonia, Viral; Pulmonary Fibrosis; SARS-CoV-2; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor | 2020 |
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
Topics: Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds; Catechin; Humans; Hypericum; Matrix Metalloproteinases; Neovascularization, Pathologic; Phloroglucinol; Pulmonary Fibrosis; Tea; Terpenes | 2007 |
A new function of green tea: prevention of lifestyle-related diseases.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Catechin; Cohort Studies; Cricetinae; Female; Gene Expression Regulation; Humans; Interleukin-6; Japan; Life Style; Lung; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; NF-kappa B; Okadaic Acid; Phytotherapy; Primary Prevention; Prospective Studies; Pulmonary Fibrosis; Rats; Risk; Tea; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2001 |
9 other study(ies) available for catechin and Pulmonary Fibrosis
| Article | Year |
|---|---|
Nano-enabled delivery of EGCG ameliorates silica-induced pulmonary fibrosis in rats.
Topics: Animals; Catechin; Nanoparticles; Pulmonary Fibrosis; Rats; Silicon Dioxide; Silicosis | 2022 |
Epigallocatechin-3-gallate (EGCG) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein A2 via a proteasomal degradation pathway.
Topics: Animals; Butylamines; Catechin; CHO Cells; Cricetulus; Cysteine Proteinase Inhibitors; Detergents; Gene Expression; Leupeptins; Mutation; Octoxynol; Proteasome Endopeptidase Complex; Protein Aggregates; Protein Stability; Proteolysis; Pulmonary Fibrosis; Pulmonary Surfactant-Associated Protein A; Recombinant Proteins; Solubility | 2019 |
Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis.
Topics: Antioxidants; Biomarkers; Biopsy; Catechin; Collagen Type I; Humans; Pulmonary Fibrosis; Snail Family Transcription Factors; Transforming Growth Factor beta1 | 2020 |
Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
Topics: Animals; Antioxidants; Biomarkers; Bleomycin; Catalase; Catechin; Disease Models, Animal; Glutathione Peroxidase; Hydroxyproline; Inflammation; Lung; Male; Malondialdehyde; Mice; Oxidative Stress; Protective Agents; Pulmonary Fibrosis; Superoxide Dismutase | 2019 |
The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats.
Topics: Actins; Animals; Antioxidants; Catechin; Dexamethasone; Gamma Rays; Gene Expression; Heme Oxygenase-1; Hydroxyproline; Injections, Intraperitoneal; Interleukin-10; Interleukin-6; Lung; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Pulmonary Fibrosis; Pulmonary Surfactant-Associated Protein B; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Tea; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2014 |
Enhancement of antioxidant defense system by epigallocatechin-3-gallate during bleomycin induced experimental pulmonary fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Ascorbic Acid; Bleomycin; Body Weight; Catechin; Glutathione; Injections, Intraperitoneal; Lung; Male; Organ Size; Pulmonary Fibrosis; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Vitamin E | 2008 |
Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Catechin; Collagen; Fluorescent Antibody Technique; Immunohistochemistry; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung; Male; Mast Cells; Microscopy, Confocal; Proteins; Pulmonary Fibrosis; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2009 |
Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Bronchoalveolar Lavage Fluid; Catechin; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar | 2009 |
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Catechin; Collagen; Drug Combinations; Fluorescein-5-isothiocyanate; Humans; Injections, Subcutaneous; Laminin; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neovascularization, Pathologic; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; Oxidants; Plant Extracts; Proteoglycans; Pulmonary Fibrosis; Tea | 2003 |